Tracks frailty and health in older adults living with HIV
Follows older people with HIV over 10 years to study frailty and its outcomes.
Plain-language title generated from the registry record
Registry title: Frailty in Older HIV-infected Individuals
Key facts
- Where
- Shatin, Hong KongSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study is looking for older people living with HIV in Hong Kong. It measures frailty and follows people over time for quality of life and survival.
- Age
- 50 years or older
- Sex
- All sexes
- Biomarker or test result
- HIV infection with a positive anti-HIV antibody test
Main reasons for not taking part
- People who refuse to give consent
Read by machine on 12 November 2026.
Where in Hong Kong
- Prince of Wales HospitalShatin, Hong KongContact: Rity WongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Chinese University of Hong Kong
- Trial code
- NCT03413683
- Record updated
- 30 August 2023
- Original description
Frailty has been proposed as a measure of biological (as opposed to chronological) aging. In this study the investigators plan to: (1) measure frailty in a cohort of older HIV-infected individuals in Hong Kong, and its association with mortality and quality of life; (2) identify risk factors predictive of development of frailty in HIV-infected individuals in Hong Kong; and (3) determine the outcomes of HIV-infected individuals in Hong Kong with and without frailty.Read full original descriptionShow less
Frailty in Older HIV-infected Individuals in Hong Kong: Risk Factors and Association With Quality of Life and Mortality
Frailty has been proposed as a measure of biological (as opposed to chronological) aging. In this study the investigators plan to: (1) measure frailty in a cohort of older HIV-infected individuals in Hong Kong, and its association with mortality and quality of life; (2) identify risk factors predictive of development of frailty in HIV-infected individuals in Hong Kong; and (3) determine the outcomes of HIV-infected individuals in Hong Kong with and without frailty.
The following assessment will be done:
1. Physical examination including measuring height, weight, hip and waist circumference. 2. Grip strength, chair stand test, gait speed test, balance tests, and neurocognitive tests 3. Geriatric syndromes, screening for depression, disability and quality of life. 4. Blood tests during fasting state to measure metabolic parameters.
This is a prospective longitudinal observational study that lasts for 10 years.
Inclusion: HIV infection with positive anti-HIV antibody; Age ≥50 years.
Exclusion: Refuses to consent.